PPT-Antithrombotic Therapy for VTE:

CHEST Guidelines 2016 Jennifer Mah MD March 2016 Case A 44yearold man is evaluated in followup for an episode of unprovoked left proximal leg deep venous thrombosis 3 months ago Following initial anticoagulation with lowmolecularweight heparin he began treatment with . Eliot Williams, MD PhD. Division of Hematology & Medical Oncology. Nothing to disclose. History of anticoagulant therapy. 1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 2010. Charles . Levenback. , MD. Professor and Deputy Chair for Patient Care. Gynecologic Oncology Center Medical Director. Lisa Kidin, RN, MSN, MHA. Sr. Business Systems Analyst. Deep vein thrombosis (DVT):. Updates and Clarification to the Process. This NetLearning is meant to clarify common confusion regarding the VTE Prophylaxis Process. . If you did not attend a Meaningful Use Class or take the original NetLearning, “Meaningful Use Mandatory NetLearning”, please view both to ensure that you understand the process completely!. Thromboembolism. N . Engl. J Med. 2012;366:1959-67. VTE Prevalence. Incidence . of DVT: 48 per 100,000. Incidence of PE: 23 per 100,000. Case-fatality rate. Inpatient: 12%. 1-year: 19%; 3-year: 30%. (EINSTEIN CHOICE). Ryan Sparks, . PharmD. , BCPS. PGY2 Cardiology Resident. WakeMed. Health & . Hosptials. Raleigh, NC. Dr. . Ryan Sparks (presenter). Current PGY2 Cardiology Resident at . WakeMed. How Do Real-World Data Fit In? . Program Goals. VTE Is a Leading Cause of Death Worldwide. NOACs: VTE Clinical Trials. Real-World Data. XALIA. A Prospective, Noninterventional Study. EINSTEIN-DVT and XALIA: Outcomes. The Best of Both Worlds in CAD/PAD: The Emerging Role of Anticoagulants Program Goals Anticoagulants in CAD PAD and AP Therapies Antithrombotic Strategies for PAD Antithrombotic Strategies for PAD (cont) An Educational Slide Set . American Society of Hematology 2018 Guidelines . for Management of Venous Thromboembolism. Slide set authors: . E. ric. Tseng MD . MScCH. , University of Toronto. Daniel Witt PharmD, University of Utah. Objectives. Define VTE and discuss the incidence of VTE. Articulate risk factors for VTE. Discuss primary and secondary prevention. Review current guidelines. A Case…. A 12-year-old male with history of intractable epilepsy underwent right-sided craniotomy with grid placement for seizure mapping. He has a PICC line in place due to difficult IV access, and he is on bedrest. Pregnancy for women with complex needs. Maternity service update. Antenatal VTE assessment. Dr Lauren Ward – CCG clinical lead for preconception and antenatal care. Background – venous thromboembolism. Special Situations. Atrial Thrombus Treatment Options. Algorithm. A Few Notes on Special Situations. Bridging. Reversal. In Your Leisure Time. Review: . Kearon et al. Antithrombotic Therapy for VTE Disease : CHEST Guideline and Expert Panel Report. . surgery. -. . new . approaches. Assoc. . Prof. Tatjana Šimurina MD, . PhD. General . Hospital Zadar; Dept. of Health Study, University of Zadar; . Medical . faculty, University of Osijek . tsimurina@unizd.h. An Educational Slide Set . American Society of Hematology 2018 Guidelines . for Management of Venous Thromboembolism. Slide set authors: . E. ric. Tseng MD, . MScCH. , University of Toronto and . Paul . Assoc. iate. . . Prof Tatjana Šimurina MD, PhD. General Hospital Zadar; . Dept. .. . of Health Study, University of Zadar; . Assist Prof - Medical faculty, University of Osijek . tsimurina@unizd.hr.